Condition: Congenital Heart Defect · Cardiac Function · Sponsor: Anna Erenbourg
The goal of this international multicentre prospective observational cohort study with a nested case-control study is to test some automated fetal heart functional parameters in healthy babies compared to those affected by a congenital heart condition. The main questions it aims to answer are: * If there is a significant difference between the two populations of infants * Whether these parameters could significantly improve the predictive value of actual cardiovascular profile score to predict hydrops Participants will be offered two automated cardiac function assessments between 27+6 and 29+6 gestational weeks and between 34+6 and 36+6 weeks of gestation. Functional parameters will be compared between the two study groups and evaluated over time.
This description comes directly from the study's public registry record.
Anna Erenbourg, MD · +61423879866 · a.erenbourg@unsw.edu.au
Alec W Welsh, MD PhD · alec.welsh@unsw.edu.au
Always discuss trial participation with your own doctor first.
| Royal Hospital for Women | Sydney, New South Wales, Australia | Recruiting |
| Sheba Medical Center | Tel Aviv, Israel | Not Yet Recruiting |
| San Salvatore Hospital L'Aquila | L’Aquila, Italy | Not Yet Recruiting |
| Vittore Buzzi Children's Hospital | Milan, Italy | Not Yet Recruiting |
| Institute for Maternal and Child Health IRCCS Burlo Garofolo | Trieste, Italy | Not Yet Recruiting |
| Centre Hospitalier de Mayotte | Mamoudzou, Mayotte | Not Yet Recruiting |
| Medical Center Ujastek | Krakow, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05698277